Open AccessAbstract 5012: Mouse-human co-clinical trials demonstrate superior efficacy with combinational approach of BKM120 and erbitux over BKM120 monotherapy in patients with recurrent and/or metastatic squamous cell carcinoma of head and neck (R/M-SCCHN)
Author(s) -
Han Sol Kang,
Mi Ran Yun,
KyoungHo Pyo,
Min Ahn,
JongMu Sun,
Sun Min Lim,
Soonmyung Paik,
Byoung Chul Cho,
Hye Ryun Kim
Publication year - 2017
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2017-5012
Subject(s) - medicine , clinical endpoint , clinical trial , oncology , chemotherapy , progression free survival , surgery , gastroenterology